Lab notes: Temple spinout advances gene-editing HIV treatment; 3 firms make board appointments

This week's roundup of life sciences industry news includes updates on a Philadelphia gene-editing company and a biotech firm based at Cheyney University.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.